Craig Brown and Sue Smith Endowed Postdoctoral Fellowship in Cancer Immunology
Overview: The Smith and Brown Endowed Postdoctoral Fellowship in Cancer Immunology is a prestigious opportunity for highly motivated individuals who have recently graduated with a Ph.D. or M.D. Ph.D. degree in cancer immunobiology or a related field (within a maximum of 2 years after obtaining their degree). This fellowship program is dedicated to the advancement of cancer immunology and immunotherapy, with a focus on the development of innovative preventive vaccines and therapeutic devices and platforms that harness the body's own immune system to combat cancer effectively. The successful candidate will also have the opportunity to work at the forefront of cell engineering and explore the potential for local cell recruitment and reprogramming. This fellowship supports individuals to conduct research training in the Grattoni’s Laboratory at the Houston Methodist Hospital, in Houston Texas. Houston Methodist Hospital, situated in the heart of the Texas Medical Center, the world's largest medical complex, is at the forefront of medical innovation and research. With a strong emphasis on translating cutting-edge biomedical technologies into clinical practice, it stands as a beacon of excellence in healthcare, delivering state-of-the-art patient care and advancing the boundaries of medical science.
Qualifications and Expertise:
The ideal candidate for this fellowship will meet the following qualifications and requirements:
Research Focus:
The fellowship will revolve around the development of innovative strategies to elicit potent anti-cancer responses from the immune system. This involves investigating and creating preventive vaccines and therapeutic platforms, pushing the boundaries of our understanding of immunology and cell engineering. The research may include exploring local cell recruitment and reprogramming techniques that hold promise in the fight against cancer.
Benefits and Support:
Application Process:
Applicants interested in the Smith and Brown Endowed Postdoctoral Fellowship in Cancer Immunology are encouraged to submit their application materials, including their CV, a cover letter outlining their research interests, contact information for 3 references, and a list of their first-author publications. The selection process will be highly competitive, and candidates with a demonstrated passion for advancing cancer immunology, the qualifications mentioned above, and a strong publication record will be given preference.
This fellowship provides a unique platform for recent graduates to make a significant impact in the field of cancer immunology and immunotherapy, contribute to groundbreaking research, and gain valuable experience in a collaborative and innovative environment. Join us in the pursuit of advancing cancer immunology and developing transformative approaches to cancer treatment.
Contacts
Email: Grattonilab@houstonmethodist.org
Webpage: https://grattoni.hmailabs.org/
The Craig and Galen Brown Foundation:
The Craig and Galen Brown Foundation (“Brown Foundation”) scholarship program was formalized in 1992 with the awarding of four undergraduate scholarships to high achieving, well rounded students with demonstrated leadership who achieved National Merit status, attended Texas A&M University (“A&M”) and pursued STEM majors, principally in engineering, science and business. Since its humble beginnings, the Brown Foundation has awarded 600+ undergraduate scholarships. Students, known as Brown Scholars, are recognized on the A&M campus as exceptional students and leaders and have held every leadership position on campus and in their chosen professions and include physicians, researchers, inventors, entrepreneurs, CEO’s, executive managers and business owners.
Beginning in 2019, the Brown Foundation awarded Engineering Medicine (“EnMed”) graduate scholarships to a subset of students who were offered undergraduate scholarships and attended A&M majoring in engineering disciplines. EnMed is a first in the nation program where students receive MD and Master of Engineering degrees in four years. The Brown Foundation annually proffers 15+ high school students for admission to EnMed using the E2EnMed Early Assurance Program pathway. Currently 40+ Brown Scholars across 4 classes will matriculate to EnMed.
Craig Brown is the Founder and Chairman of the Brown Foundation and his wife, Sue Smith, serves as Executive Vice President.
The average Brown Scholar GPA is 3.89. The average EnMed Brown Scholar GPA is 3.98 and the average MCAT score is 520, 97%.
PATIENT AGE GROUP(S) AND POPULATION(S) SERVED
Refer to departmental "Scope of Service" and "Provision of Care" plans, as applicable, for description of primary age groups and populations served by this job for the respective HM entity.
HOUSTON METHODIST EXPERIENCE EXPECTATIONS
PEOPLE ESSENTIAL FUNCTIONS
SERVICE ESSENTIAL FUNCTIONS
QUALITY/SAFETY ESSENTIAL FUNCTIONS
FINANCE ESSENTIAL FUNCTIONS
GROWTH/INNOVATION ESSENTIAL FUNCTIONS
This job description is not intended to be all-inclusive; the employee will also perform other reasonably related business/job duties as assigned. Houston Methodist reserves the right to revise job duties and responsibilities as the need arises.
EDUCATION
WORK EXPERIENCE
LICENSES AND CERTIFICATIONS - REQUIRED
KNOWLEDGE, SKILLS, AND ABILITIES
SUPPLEMENTAL REQUIREMENTS
WORK ATTIRE
ON-CALL*
*Note that employees may be required to be on-call during emergencies (ie. DIsaster, Severe Weather Events, etc) regardless of selection below.
TRAVEL**
**Travel specifications may vary by department**
Houston Methodist Research Institute was formed in 2004 to rapidly and efficiently translate discoveries made in the laboratory and the clinic into new diagnostics, therapies, and treatments. The research institute was created to provide the infrastructure and support for these endeavors, and to house the technology and resources needed to make innovative breakthroughs in important areas of human disease. A 540,000 square foot building dedicated to research, the research institute houses over 1,500 staff and trainees, 284 principal investigators and has more than 570 ongoing clinical trials.
Software Powered by iCIMS
www.icims.com